Inactive Instrument
Sector Cell Therapeutics Inc Nasdaq
Stocks
US1509346029
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 26/06/23 | DRI Healthcare Trust Receives US$54.8 Million in Debt Repayment | MT |
| 26/06/23 | DRI Healthcare Trust Announces USD 54.8 Million Debt Repayment from CTI Biopharma Corp | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.86% | -4.75% | -6.50% | +6.99% | -1.52% | -3.22% | +6.47% | -30.99% | +192.44% | 45.63B | |
| +0.66% | -2.34% | +0.69% | +33.30% | +157.51% | +340.62% | +530.14% | +594.11% | - | 43.96B | |
| +1.49% | -0.78% | +12.26% | +46.41% | +17.86% | +41.90% | +24.75% | +3.15% | +241.04% | 43.73B | |
| +2.11% | -1.24% | +1.83% | +33.78% | +16.46% | +9.09% | +78.25% | -4.08% | +953.69% | 40.23B | |
| +0.34% | -4.03% | -11.04% | +3.35% | +3.72% | +9.34% | +38.90% | -17.31% | +135.16% | 31.86B | |
| +0.53% | -2.08% | +6.61% | +21.49% | - | - | - | - | - | 17.4B | |
| +1.34% | +0.70% | +2.92% | +27.40% | +6.01% | +21.35% | +112.62% | +228.83% | +1,875.48% | 16.62B | |
| +0.89% | +2.19% | +3.94% | +14.80% | +16.60% | +15.35% | +31.43% | -40.94% | +91.37% | 14.46B | |
| -1.85% | -5.33% | -2.48% | +45.65% | +36.91% | +78.63% | +31.45% | -37.39% | +239.01% | 13.04B | |
| -0.22% | +2.47% | +3.54% | +15.56% | -7.29% | -3.47% | -35.47% | -36.33% | +121.32% | 13.03B | |
| +0.21% | -0.22% | -0.18% | +33.83% | +22.89% | +40.99% | -2.39% | -43.31% | +170.14% | 11.33B | |
| +5.42% | -3.73% | +19.40% | +30.09% | +5.35% | -27.98% | - | - | - | 11.22B | |
| -2.21% | -3.51% | -7.98% | +14.51% | -19.06% | +35.91% | +492.76% | +194.41% | +983.98% | 10.02B | |
| +5.88% | +3.37% | -13.17% | +90.57% | +50.02% | +26.37% | +56.80% | -53.16% | - | 10.73B | |
| -0.27% | +1.41% | -4.72% | +34.61% | +69.20% | +151.07% | +721.00% | +227.96% | +1,028.09% | 9.56B | |
| -0.29% | -2.35% | -2.35% | +32.97% | +47.32% | +143.95% | +491.49% | +81.46% | - | 9.53B | |
| -1.20% | -6.04% | -9.89% | +24.00% | +12.15% | +776.67% | +1,582.19% | +8.61% | - | 9.23B | |
| -4.76% | -6.63% | +24.16% | +174.41% | +160.71% | +89.91% | +66.56% | -0.98% | +1,179.84% | 9.48B | |
| -5.11% | -11.45% | -10.13% | -29.80% | -34.98% | -18.56% | +17.87% | +42.06% | +68.88% | 8.55B | |
| Average | -0.25% | -1.28% | +0.36% | +34.42% | +31.10% | +96.00% | +249.70% | +65.65% | +560.03% | 19.45B | |
| Weighted average by Cap. | +0.23% | -1.64% | +0.55% | +30.36% | +34.80% | +86.17% | +187.19% | +89.89% | +495.54% |
- Stock Market
- Stocks
- CTIC Stock
- Stock
- Sector Cell Therapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
